Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)

Solange Peters, Enriqueta Felip, Urania Dafni, Amanda Tufman, Matthias Gückenberger, Ruth Álvarez, Ernest Nadal, Annemarie Becker‐Commissaris, Hansjörg Vees, Miklos Pless, Alex Martínez‐Martí, Maarten Lambrecht, Nicolaus Andratschke, Zoi Tsourti, Anne‐Christine Piguet, Heidi Roschitzki‐Voser, A. Gasca-Ruchti, Johan Vansteenkiste, Rolf A. Stahel, Dirk De Ruysscher